Evidence map›Paper›PMID 24042033›Full record

ArticleNeuroscience2013

Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury.

J D Figueroa, K Cordero, M Serrano-Illan, A Almeyda, K Baldeosingh, F G Almaguel, M De Leon

Open access · hybridAbstract read
In one paragraph

Article in Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Lesion level and severity acutely influence metabolomic profiles in spinal cord injury.Journal of neuropathology and experimental neurology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J D FigueroaCenter for Health Disparities and Molecular Medicine, Loma Linda University, Loma Linda, CA, United States; Department of Basic Sciences, Loma Linda University, Loma Linda, CA, United States; Department of Pathology and Human Anatomy, Loma Linda University, Loma Linda, CA, United States.
K Cordero
M Serrano-Illan
A Almeyda
K Baldeosingh
F G Almaguel
M De Leon
Loma Linda University · US

Funding

NIH-LLU Initiative for Maximizing Student DiversityR25GM060507 · NIGMS · LOMA LINDA UNIVERSITY · PI DE LEON, MARINO · 2001 to 2022
$11.3M
The role of imidazoline receptor in type-2 diabetesP20MD001632 · NIMHD · LOMA LINDA UNIVERSITY · PI DE LEON, DAISY D. · 2005 to 2009
$8.0M
Research Training/Education CoreP20MD006988 · NIMHD · LOMA LINDA UNIVERSITY · PI DE LEON, MARINO · 2012 to 2016
$6.2M
NIGMS NIH HHS 5R25GM060507NIGMS NIH HHS R25 GM060507NIMHD NIH HHS 1P20MD006988NIMHD NIH HHS P20 MD001632NIMHD NIH HHS P20 MD006988
6 · The paper itself

Abstract

Chronic neuropathic pain is a frequent comorbidity following spinal cord injury (SCI) and often fails to respond to conventional pain management strategies. Preventive administration of docosahexaenoic acid (DHA) or the consumption of a diet rich in omega-3 polyunsaturated fatty acids (O3PUFAs) confers potent prophylaxis against SCI and improves functional recovery. The present study examines whether this novel dietary strategy provides significant antinociceptive benefits in rats experiencing SCI-induced pain. Rats were fed control chow or chow enriched with O3PUFAs for 8weeks before being subjected to sham or cord contusion surgeries, continuing the same diets after surgery for another 8 more weeks. The paw sensitivity to noxious heat was quantified for at least 8weeks post-SCI using the Hargreaves test. We found that SCI rats consuming the preventive O3PUFA-enriched diet exhibited a significant reduction in thermal hyperalgesia compared to those consuming the normal diet. Functional neurometabolomic profiling revealed a distinctive deregulation in the metabolism of endocannabinoids (eCB) and related N-acyl ethanolamines (NAEs) at 8weeks post-SCI. We found that O3PUFAs consumption led to a robust accumulation of novel NAE precursors, including the glycerophospho-containing docosahexaenoyl ethanolamine (DHEA), docosapentaenoyl ethanolamine (DPEA), and eicosapentaenoyl ethanolamine (EPEA). The tissue levels of these metabolites were significantly correlated with the antihyperalgesic phenotype. In addition, rats consuming the O3PUFA-rich diet showed reduced sprouting of nociceptive fibers containing CGRP and dorsal horn neuron p38 mitogen-activated protein kinase (MAPK) expression, well-established biomarkers of pain. The spinal cord levels of inositols were positively correlated with thermal hyperalgesia, supporting their role as biomarkers of chronic neuropathic pain. Notably, the O3PUFA-rich dietary intervention reduced the levels of these metabolites. Collectively, these results demonstrate the prophylactic value of dietary O3PUFA against SCI-mediated chronic pain.

Indexed as

MetabolomicsAnimalsChromatography, High Pressure LiquidDietary FatsDisease Models, AnimalFatty Acids, Omega-3FemaleFluorescent Antibody TechniqueHyperalgesiaRatsRats, Sprague-DawleySpinal Cord InjuriesTandem Mass SpectrometryDietary FatsFatty Acids, Omega-31-OG1-oleoyl glycerol2-AG2-arachidonoyl glycerol2-palmitoyl glycerol2-PGAbh4AEAarachidonoyl ethanolamineBasso, Beattie and BresnahanBBBcalcitonin gene-related peptideCGRPchronic painDHADHEAdietary fatty acidsdocosahexaenoic aciddocosahexaenoyl ethanolamine/synaptamidedocosapentaenoyl ethanolamineDPEAeCBsEGeicosapentaenoyl ethanolamineeicosenoyl glycerolendocannabinoid metabolomeendocannabinoidsEPAEPEAG3PGAP43gas chromatography/mass spectrometryGC/MSGDE1glycerol-3-phosphateglycerophospho-containing N-acyl ethanolaminesglycerophosphodiesteraseGP-NAEsgrowth-associated protein 43hindpaw withdrawal latencyHWLLEAlinoleyl ethanolamineLPAlyso-phosphatidic acidMAPKmitogen-activated protein kinaseN-acyl ethanolaminesN-acyl phosphatidyl ethanolamineNAEsNAPEO3PUFAsomega-3 polyunsaturated fatty acidsPApalmitoyl ethanolaminepartial least square-discriminant analysisPEAphosphatidic acidphospholipase A/B or α-β-hydrolase 4phospholipase DPLDPLS-DASCIspinal cord injuryTHthermal hyperalgesiaUHPLC/MS/MS(2)ultrahigh performance liquid chromatography/tandem mass spectrometry

Identifiers

PMID24042033
PMCPMC3844071
OpenAlexW2000939065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.